FDA Announces Recall of Blood Pressure Medications Over High Levels of Possible Carcinogenic—Here's What to Do

Health Magazine 2021-10-21

Views 726

The voluntary recall by Lupin Pharmaceuticals involves Irbesartan tablets as well as its Irbesartan and Hydrochlorothiazide tablets.

Share This Video


Download

  
Report form